hair loss after semaglutide Reddit threads and social media posts are buzzing about a connection between Does Semaglutide or Tirzepatide Cause

In children, it can result in stunted growth

Not buffered creatine

Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono

6.3 Cancer Uncontrolled cell proliferation, apoptosis evasion, prolonged angiogenesis, and metastasis are the hallmarks of cancer, which continues to rank among the worlds top causes of illness and mortality (36)

Missing or delaying doses can lead to breakthrough hunger and diminished weight loss outcomes, so consistent weekly injection is essential

So it was welcome news in April when Blue Cross Blue Shield of Massachusetts announced it would stop covering GLP-1 drugs for weight loss, beginning Jan